The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy.


Journal

The Lancet. Child & adolescent health
ISSN: 2352-4650
Titre abrégé: Lancet Child Adolesc Health
Pays: England
ID NLM: 101712925

Informations de publication

Date de publication:
11 2020
Historique:
received: 31 03 2020
revised: 22 05 2020
accepted: 29 05 2020
pubmed: 18 10 2020
medline: 12 11 2020
entrez: 17 10 2020
Statut: ppublish

Résumé

For decades, radiotherapy with two opposing photon beams has been the standard technique used to cover the flank target volume in paediatric patients with renal tumours. Nowadays, many institutes are implementing advanced radiotherapy techniques that spare healthy tissue. To decrease the radiotherapy dose to healthy structures while preserving oncological efficacy, the conventional approach of flank irradiation has been adapted into a guideline for highly conformal flank target-volume delineation by paediatric radiation oncologists and representatives of the International Society of Paediatric Oncology's Renal Tumour Study Group (SIOP-RTSG) board during four live international consensus meetings. The consensus was refined by delineation exercises and videoconferences by ten collaborating paediatric radiation oncologists. The final guideline includes eight chronological steps to generate the tumour bed and clinical, internal, and planning target volumes, and it describes the optional use of surgical clips to optimise treatment planning. This guideline will be added into the radiotherapy guideline of the UMBRELLA SIOP-RTSG protocol for paediatric renal tumours to improve international consistency of highly conformal flank target-volume delineation.

Identifiants

pubmed: 33068550
pii: S2352-4642(20)30183-8
doi: 10.1016/S2352-4642(20)30183-8
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

846-852

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Geert O Janssens (GO)

Department of Radiation Oncology, University Medical Centre Utrecht, Utrecht, Netherlands; Princess Máxima Centre for Pediatric Oncology, Utrecht, Netherlands. Electronic address: g.o.r.janssens@umcutrecht.nl.

Patrick Melchior (P)

Department of Radiation Oncology, Saarland University Hospital, Homburg, Germany.

Joeri Mul (J)

Princess Máxima Centre for Pediatric Oncology, Utrecht, Netherlands.

Daniel Saunders (D)

Department of Clinical Oncology, The Christie Hospital, Manchester, United Kingdom.

Stephanie Bolle (S)

Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.

Alison L Cameron (AL)

Bristol Cancer Institute, University Hospital Bristol, Bristol, United Kingdom.

Line Claude (L)

Department of Radiation Oncology, Centre Léon Bérard, Lyon, France.

Kristin Gurtner (K)

Department of Radiation Oncology, University Hospital Carl Gustav Carus, Dresden, Germany.

Kees P van de Ven (KP)

Princess Máxima Centre for Pediatric Oncology, Utrecht, Netherlands.

Martine van Grotel (M)

Princess Máxima Centre for Pediatric Oncology, Utrecht, Netherlands.

Semi Harrabi (S)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.

Yasmin Lassen-Ramshad (Y)

Department of Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

Naomi Lavan (N)

St Luke's Radiation Oncology Network, Dublin, Ireland.

Henriette Magelssen (H)

Department of Oncology, Oslo University Hospital, Oslo, Norway.

Xavier Muracciole (X)

Department of Radiation Oncology, Assistance Publique des Hopitaux de Marseille, Marseille, France.

Tom Boterberg (T)

Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.

Henry Mandeville (H)

Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.

Jan Godzinski (J)

Department of Paediatric Surgery, Marciniak Hospital, Wroclaw, Poland; Department of Paediatric Traumatology and Emergency Medicine, Wroclaw Medical University, Wroclaw, Poland.

Norbert Graf (N)

Department of Pediatric Oncology, Saarland University Hospital, Homburg, Germany.

Marry M van den Heuvel-Eibrink (MM)

Princess Máxima Centre for Pediatric Oncology, Utrecht, Netherlands.

Christian Rübe (C)

Department of Radiation Oncology, Saarland University Hospital, Homburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH